The North American Society for Interventional Thyroidology (NASIT) is a multidisciplinary group of physicians and scientists who work collaboratively to promote the safe integration of ablative technologies into clinical practice, and supports education and research efforts in the field of Interventional Thyroidology.
With a specific commitment to furthering innovations in science and technology, NASIT recognizes the importance of collaborative partnerships with industry, and offer multiple opportunities to showcase the many innovations that have a role in the management of thyroid disease, including our
· Annual Meeting held every March that attracts physicians from all specialties who have a vested interest in interventional thyroidology and looking to either start or advance their own programs. The annual meeting hosts a Tech Expo with dedicated presentations showcasing select technology, and exhibitor booths that allow for meaningful engagement between physicians and industry
· biannual hands-on courses that allow for course participants to work with featured products of select partner companies
· quarterly webinars that allow for highlighting of specific products and facilitates communication with a wider reach of physicians interested in interventional thyroidology.
NASIT welcomes the opportunity to partner with companies who are dedicated to advancements in the field of Interventional Thyroidology. For companies interested in partnering with NASIT and help support our overall mission, the following table summarizes the various levels of sponsorship available each year.
Companies also have a unique opportunity to support education and training within Interventional Thyroidology by participating in our Educational Grant Program and funding one of our travel training grants. The program establishes a named corporate education grant that will provide support for a NASIT member to travel and train in a new interventional technique for 5 years.
If you are interested in potentially funding a educational traveling grant, please contact us.